MAP2K7 and sinus histiocytosis with massive lymphadenopathy: Moreover, tumor sequencing and targeted therapies, such as MEK inhibitors, have gained popularity in the last few years and may have clinical applications in RDD diagnosis and management, though the evidence remains limited [5,33].